Latest filing published 07 Jun 2023 for Pacira BioSciences, Inc., €37k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Dennis McLoughlin: trading record in brief
Dennis McLoughlin, listed as senior executive, appears in our data through filings on Pacira BioSciences, Inc. shares, published by SEC (Form 4). In total, 11 filings cover trades dated from 4 June 2019 to 7 June 2023.
On the market, this insider has only sold: 7 sales, €545k in total. Besides market trades, the filings include 4 share grants. 2023 to date brings no purchases and 2 sales.
The latest filing, published on 7 June 2023, reports an open-market sale of €37k in Pacira BioSciences, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dennis McLoughlin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,014 shares@ US$38.99110.5% of flowCommon StockSEC:0001209191-23-035258:0
- 2,140 shares@ US$61.3740.012% mcap39.2% of flowCommon StockSEC:0001209191-22-035225:0
- 6,000 shares0Common StockSEC:0001209191-21-040098:0
- 1,895 shares@ US$61.03737.4% of flowCommon StockSEC:0001209191-21-038884:0
4 of 4 declarations
